VIDEO: Cantor's Dentice sees personalized medicine spurring M&A - The Deal Pipeline (SAMPLE CONTENT: NEED AN ID?)
Subscriber Content Preview | Request a free trialSearch  
  Go

Healthcare

Print  |  Share  |  Reprint

VIDEO: Cantor's Dentice sees personalized medicine spurring M&A

by Sarah Hashim-Waris  |  Published July 17, 2012 at 4:00 AM


Robert Dentice, managing director and co-head of Cantor Fitzgerald & Co.'s healthcare investment banking unit predicts that healthcare content companies with diagnostic tests that aid in personalized medicine will become hot M&A targets for drugmakers and other life sciences companies. - George White


Share:
Tags: biotech | Cantor Fitzgerald | healthcare | M&A | personalized medicine | Robert Dentice

Free preview

This is only a preview of The Deal's sophisticated coverage. Explore the real-time intelligence as researched and reported on by our team of financial journalists with a license to The Deal Pipeline. Click here for more information.

Meet the journalists

Sarah Hashim-Waris

Video reporter

Contact



Movers & Shakers

Launch Movers and shakers slideshow

NBGI Private Equity appointed food and drinks industry veteran Tim Kelly as a senior adviser. For other updates launch today's Movers & shakers slideshow.

Video

Shop, then chop

Blackstone Real Estate and DDR divide 46 shopping centers in a $1.46 billion deal. More video

Sectors